MedTrace Logo

IISART (International Industry Society of Advanced Rehabilitation Technology) Advanced Rehabilitation Technology Study

NCT05652946 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2022-12-15

No results posted yet for this study

Summary

A pre-post, randomized control trial comparing cost-effective and functional outcomes of participants with neurological diagnoses using robotic devices and advanced technology during inpatient rehabilitation to the outcomes of control participants without the use of robotic devices and advanced technology during rehabilitation. We aim to show at least similar inpatient rehabilitation outcomes and improved health economics in participants with neurological diagnoses by using robotic devices and advanced technology to increase the intensity and dose of rehabilitation.

Conditions

  • Neurologic Disorder

Interventions

DEVICE

Tyromotion, Fourier Intelligence, Thera-Trainer, EKSO Bionics

Participants to receive at least 5 sessions with advanced rehabilitation technology including at least one, or multiple, of the following devices: Amadeo, Diego, Myro, Arm Motus EMU, Pelma Motus, Tigo, Balo, EKSO NR. Sessions are 45 (+/- 5) minutes

OTHER

Standard inpatient rehabilitation therapy

Standard inpatient rehabilitation therapy without advanced rehabilitation technology

Sponsors & Collaborators

  • Discovery Statistics

    collaborator UNKNOWN

  • Rehabilitation Hospital of Overland Park

    lead INDUSTRY

Principal Investigators

  • Brett Schoen, MD · Rehabilitation Hospital of Overland Park

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-17
Primary Completion
2024-10-17
Completion
2025-01-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05652946 on ClinicalTrials.gov